NEW YORK (GenomeWeb News) — Accelr8 Technology today said that total year-end revenue fell by more than half as net losses increased by roughly half.
 
Revenue for the 12 months ended July 31 slid to $212,000 from $500,000 in 2005, and the company lost $3 million on the year, about 50 percent more than last year.
 
The company said in 2006 it completed its transition to an R&D operation, with its resources directed towards its BACcelr8r platform, particularly towards its BACcel-1.0.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.